POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.

Senate Hearing: Improving Transparency in How Agencies Use Science

Original title: AGENCY USE OF SCIENCE IN THE RULEMAKING PROCESS: PROPOSALS FOR IMPROVING TRANSPARENCY AND ACCOUNTABILITY

Record date · January 1, 2017

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

This Senate subcommittee hearing examined how federal agencies use scientific data to create new regulations. The discussion focused on proposals to ensure that the information used by agencies is transparent, , and .

Why it matters

The hearing explores potential changes to federal standards for scientific evidence, which could alter the data requirements for future environmental, health, and safety regulations.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Federal Regulatory Agencies

These agencies may be subject to new standards for how they evaluate and document the scientific evidence used in their rulemaking processes.

Directly affected

Scientific Research Community

Researchers may face new requirements for data transparency and reproducibility if their work is used to support federal regulations.

Key Facts

  • The hearing took place on March 9, 2017, in the Dirksen Senate Office Building.
  • The subcommittee is reviewing how federal agencies select and utilize scientific information for regulatory decision-making.
  • Proposed criteria for 'best available information' include independent peer review, reproducibility of results, and public availability of data.
  • The hearing is part of a multi-year review of the federal rulemaking process by the subcommittee.
Show all 5 facts
  • Witnesses included representatives from academic, scientific advocacy, and industry policy organizations.

Frequently Asked Questions

What is the goal of this hearing?
To discuss ways to improve the transparency and accountability of the scientific data used by federal agencies when they write new rules.
What criteria were suggested for evaluating scientific data?
Suggestions included ensuring data is , , transparent, and publicly available.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Focus on Reproducibility

The hearing highlights a shift toward prioritizing 'reproducibility' as a mandatory standard for scientific data in federal rulemaking.

Connected Entities

Andrew A. Rosenberg, Subcommittee on Regulatory Affairs and Federal Management, Nancy Beck and 2 more
PersonAndrew A. Rosenberg“Director of the Center for Science and Democracy at the Union of Concerned Scien”Map →
OrganizationSubcommittee on Regulatory Affairs and Federal Management“Senate subcommittee conducting the hearing”Map →
PersonNancy Beck“Senior Director of Regulatory Science Policy at the American Chemistry Council”Map →
PersonSusan Dudley“Director of the Regulatory Studies Center at The George Washington University”Map →
PersonJames Lankford“Chairman of the Subcommittee on Regulatory Affairs and Federal Management”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance65
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz20
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record